Home Cart 0 Sign in  
X

[ CAS No. 849928-26-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 849928-26-3
Chemical Structure| 849928-26-3
Chemical Structure| 849928-26-3
Structure of 849928-26-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 849928-26-3 ]

Related Doc. of [ 849928-26-3 ]

Alternatived Products of [ 849928-26-3 ]

Product Details of [ 849928-26-3 ]

CAS No. :849928-26-3 MDL No. :MFCD07779077
Formula : C10H18BrNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :YCUDHDNCZHPAJK-UHFFFAOYSA-N
M.W : 264.16 Pubchem ID :51051593
Synonyms :

Calculated chemistry of [ 849928-26-3 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.9
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 64.46
TPSA : 29.54 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.19 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.0
Log Po/w (XLOGP3) : 2.43
Log Po/w (WLOGP) : 2.4
Log Po/w (MLOGP) : 2.15
Log Po/w (SILICOS-IT) : 1.71
Consensus Log Po/w : 2.34

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.81
Solubility : 0.408 mg/ml ; 0.00155 mol/l
Class : Soluble
Log S (Ali) : -2.69
Solubility : 0.535 mg/ml ; 0.00203 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.13
Solubility : 1.97 mg/ml ; 0.00745 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.12

Safety of [ 849928-26-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 849928-26-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 849928-26-3 ]

[ 849928-26-3 ] Synthesis Path-Downstream   1~5

  • 1
  • [ 1151832-33-5 ]
  • [ 849928-26-3 ]
  • [ 1221891-68-4 ]
  • 2
  • [ 849928-26-3 ]
  • [ 182344-70-3 ]
  • [ 1612156-15-6 ]
  • 3
  • [ 104-92-7 ]
  • [ 849928-26-3 ]
  • [ 1463887-97-9 ]
  • 4
  • [ 485820-12-0 ]
  • [ 849928-26-3 ]
  • C28H43N3O6 [ No CAS ]
YieldReaction ConditionsOperation in experiment
The (R) -3_ (tert-butoxycarbonyl) piperidine-1-carboxylate was dissolved in DMF at 0_5 C, 60% sodium hydride suspension processing. The reaction mixture was warmed to room temperature lOmin, then cooled again, and a solution of 3-bromo-piperidine-1-carboxylate. After 2 hours, warmed to room temperature, an additional amount of 3-bromo-piperidine-1-carboxylate, and the reaction mixture was stirred for 16 hours. The reaction mixture was evaporated under vacuum to ~ 1/4 volume, and partitioned between ethyl acetate and water. The organic solution was then washed with brine phase portions, dried over anhydrous magnesium sulfate, filtered, and evaporated in vacuo to give a residue.
The (R) - 3 - (tert-butoxycarbonylamino) piperidine-1-carboxylic acid benzyl ester in 0-5 C is soluble in DMF, use of sodium hydride 60% suspension processing. The reaction mixture is heated to room temperature 10 min, and then again cooling, and adding 3-bromo piperidine-1-carboxylic acid T-butyl ester. 2 hours later, the temperature is increased to room temperature, adding extra amount of 3-bromo piperidine-1-carboxylic acid T-butyl ester, and stirring the reaction mixture 16 hours. Then the reaction mixture is vacuum evaporation to -1/4 volume, and allocated between the ethyl acetate and water. Then the organic phase part of the salt water solution for washing, drying with anhydrous magnesium sulfate, filtration, and vacuum evaporation to obtain the residue. The residue is dissolved in ethanol, with 10% palladium-carbon processing, and in 60-70psi hydrogenated hydrogen 6.5 hours. The crude reaction mixture is then filtered using diatomaceous earth, vacuum evaporation, and once again is soluble in ethanol, the filtration in order to remove the residual catalyst. Evaporating the mixture, ethyl acetate/hexane on a silica gel chromatography to obtain the title compound (formula: C 20 H 37 N 3 O 4).
The (R) - 3 - (tert-butoxycarbonylamino) piperidine-1-carboxylic acid benzyl ester in 0-5 C is soluble in DMF, use of sodium hydride 60% suspension processing. The reaction mixture is heated to room temperature 10 min, and then again cooling, and adding 3-bromo piperidine-1-carboxylic acid T-butyl ester. 2 hours later, the temperature is increased to room temperature, adding extra amount of 3-bromo piperidine-1-carboxylic acid T-butyl ester, and stirring the reaction mixture 16 hours. Then the reaction mixture is vacuum evaporation to -1/4 volume, and allocated between the ethyl acetate and water. Then the organic phase part of the salt water solution for washing, drying with anhydrous magnesium sulfate, filtration, and vacuum evaporation to obtain the residue.
The (R) - 3 - (tert-butoxycarbonylamino) piperidine-1-carboxylic acid benzyl ester in 0-5 C is soluble in DMF, use of sodium hydride 60% suspension processing. The reaction mixture is heated to room temperature 10 min, and then again cooling, and adding 3-bromo piperidine-1-carboxylic acid T-butyl ester. 2 hours later, the temperature is increased to room temperature, adding extra amount of 3-bromo piperidine-1-carboxylic acid T-butyl ester, and stirring the reaction mixture 16 hours. Then the reaction mixture is vacuum evaporation to -1/4 volume, and allocated between the ethyl acetate and water. Then the organic phase part of the salt water solution for washing, drying with anhydrous magnesium sulfate, filtration, and vacuum evaporation to obtain the residue.The residue is dissolved in ethanol, with 10% palladium-carbon processing, and in 60-70psi hydrogenated hydrogen 6.5 hours. The crude reaction mixture is then filtered using diatomaceous earth, vacuum evaporation, and once again is soluble in ethanol, the filtration in order to remove the residual catalyst. Evaporating the mixture, ethyl acetate/hexane on a silica gel chromatography to obtain the title compound (formula: C20H37N3O4).
The (R) -3- (tert-butoxycarbonyl) piperidine-1-carboxylate was dissolved in DMF at 0-5 , with sodium hydride 60% dispersion treatment. The reaction mixture was warmed to room temperature 10min, then cooled again, and a solution of 3-bromo-piperidine-1-carboxylate. After 2 hours, warmed to room temperature, an additional amount of 3-bromo-piperidine-1-carboxylate, and the reaction mixture was stirred for 16 hours. The reaction mixture was evaporated in vacuo and then to ~ 1/4 volume and partitioned between ethyl acetate and water. The organic portion was washed with brine solution, dried over anhydrous magnesium sulfate, filtered, and evaporated in vacuo to give a residue. The residue was dissolved in ethanol, treated with 10% palladium on carbon and hydrogen for 6.5 hours at 60-70psi. The crude reaction mixture was filtered through celite, evaporated in vacuo, and dissolved again in ethanol, filtered to remove catalyst residues. The mixture was evaporated and chromatographed on silica gel using ethyl acetate / hexane to obtain the title compound (molecular formula: C20H37N3O4).

  • 5
  • [ 849928-26-3 ]
  • [ 88597-06-2 ]
  • C21H28N2O4 [ No CAS ]
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 849928-26-3 ]

Bromides

Chemical Structure| 939793-16-5

[ 939793-16-5 ]

tert-Butyl 3-bromopyrrolidine-1-carboxylate

Similarity: 0.91

Chemical Structure| 180695-79-8

[ 180695-79-8 ]

N-Boc-4-Bromopiperidine

Similarity: 0.91

Chemical Structure| 169457-73-2

[ 169457-73-2 ]

tert-Butyl 4-(2-bromoethyl)piperidine-1-carboxylate

Similarity: 0.89

Chemical Structure| 158407-04-6

[ 158407-04-6 ]

tert-Butyl 4-(bromomethyl)piperidine-1-carboxylate

Similarity: 0.88

Chemical Structure| 188869-05-8

[ 188869-05-8 ]

tert-Butyl 3-bromo-4-oxopiperidine-1-carboxylate

Similarity: 0.87

Amides

Chemical Structure| 939793-16-5

[ 939793-16-5 ]

tert-Butyl 3-bromopyrrolidine-1-carboxylate

Similarity: 0.91

Chemical Structure| 180695-79-8

[ 180695-79-8 ]

N-Boc-4-Bromopiperidine

Similarity: 0.91

Chemical Structure| 169457-73-2

[ 169457-73-2 ]

tert-Butyl 4-(2-bromoethyl)piperidine-1-carboxylate

Similarity: 0.89

Chemical Structure| 158407-04-6

[ 158407-04-6 ]

tert-Butyl 4-(bromomethyl)piperidine-1-carboxylate

Similarity: 0.88

Chemical Structure| 188869-05-8

[ 188869-05-8 ]

tert-Butyl 3-bromo-4-oxopiperidine-1-carboxylate

Similarity: 0.87

Related Parent Nucleus of
[ 849928-26-3 ]

Aliphatic Heterocycles

Chemical Structure| 939793-16-5

[ 939793-16-5 ]

tert-Butyl 3-bromopyrrolidine-1-carboxylate

Similarity: 0.91

Chemical Structure| 180695-79-8

[ 180695-79-8 ]

N-Boc-4-Bromopiperidine

Similarity: 0.91

Chemical Structure| 169457-73-2

[ 169457-73-2 ]

tert-Butyl 4-(2-bromoethyl)piperidine-1-carboxylate

Similarity: 0.89

Chemical Structure| 158407-04-6

[ 158407-04-6 ]

tert-Butyl 4-(bromomethyl)piperidine-1-carboxylate

Similarity: 0.88

Chemical Structure| 188869-05-8

[ 188869-05-8 ]

tert-Butyl 3-bromo-4-oxopiperidine-1-carboxylate

Similarity: 0.87

Piperidines

Chemical Structure| 180695-79-8

[ 180695-79-8 ]

N-Boc-4-Bromopiperidine

Similarity: 0.91

Chemical Structure| 169457-73-2

[ 169457-73-2 ]

tert-Butyl 4-(2-bromoethyl)piperidine-1-carboxylate

Similarity: 0.89

Chemical Structure| 158407-04-6

[ 158407-04-6 ]

tert-Butyl 4-(bromomethyl)piperidine-1-carboxylate

Similarity: 0.88

Chemical Structure| 188869-05-8

[ 188869-05-8 ]

tert-Butyl 3-bromo-4-oxopiperidine-1-carboxylate

Similarity: 0.87

Chemical Structure| 193629-39-9

[ 193629-39-9 ]

N-Boc-3-(bromomethyl)piperidine

Similarity: 0.84